Open access
Oct 2026
OTULIN aggravate aneurysm/aortic dissection by promoting vascular smooth muscle cell phenotype switching via the DDX17 -FGF2 Axis
It is demonstrated that OTULIN acts as a pathological driver of AAD by destabilizing DDX17 and activating the FGF2 axis and targeting OTULIN may represent a novel therapeutic strategy for AAD.
X. Hu, H. Chen, Sha-Lei Liu et al.
· European Heart Journal · 0 citations